SCHEMBL7528034

SCHEMBL7528034

Fc1ccc(CCCCN2CCN(c3cccc4[nH]ccc34)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.57
DRD3 P35462 7/20 0.57
DRD4 P21917 3/20 0.57
GAA P10253 3/20 0.57
HTR1A P08908 5/20 0.54
HTR2A P28223 5/20 0.54
DRD1 P21728 3/20 0.54
DRD5 P21918 3/20 0.54
SIGMAR1 Q99720 3/20 0.51
HTR7 P34969 2/20 0.51
TMEM97 Q5BJF2 2/20 0.51
HRH1 P35367 2/20 0.51
ADRA2C P18825 1/20 0.51
MAPT P10636 1/20 0.50
ADRA1A P35348 1/20 0.50
CYP2C9 P11712 1/20 0.49
ADRB1 P08588 1/20 0.49
HTR6 P50406 1/20 0.49
HTR2C P28335 2/20 0.48
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL791195 0.81 DRD2 (0.61) DRD2DRD3DRD4GAAHTR1A
Hydrochloric Acid SCHEMBL6706136 0.81 DRD2 (0.53) DRD2DRD3DRD4GAAHTR1A
SCHEMBL7136001 0.81 ALDH1A1 (0.61) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL7538517 0.80 DRD2 (0.50) DRD2HTR1AHTR7ADRA1A
SCHEMBL27570335 0.80 HTR1A (0.48) DRD2DRD3DRD4GAAHTR1A
Hydrochloric Acid SCHEMBL6706211 0.80 ALDH1A1 (0.60) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL17817484 0.80 DRD2 (0.60) DRD2DRD3DRD4GAAHTR1A
SCHEMBL7094842 0.80 DRD2 (0.54) DRD2DRD3DRD4GAAHTR1A
SCHEMBL7538925 0.80 DRD2 (0.68) DRD2HTR1A
SCHEMBL792919 0.79 HTR1A (0.67) DRD2DRD3DRD4HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002030422-A1 USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA MERCK PATENT GMBH (DE) 2002-04-18 WO claimed
WO-2002030422-A1 USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA MERCK PATENT GMBH (DE) 2002-04-18 WO disclosed
WO-2002030422-A1 USE OF DEFINED SUBSTANCES THAT BIND TO THE SIGMA RECEPTOR FOR COMBATING SARCOMA AND CARCINOMA MERCK PATENT GMBH (DE) 2002-04-18 WO disclosed